Device Development - Improving Patient Experience Through Digital and Combination Products

18 September 2023 17:20 - 17:50

  • High incidence of handling errors during administration of inhalation therapies are still reported.
  • Development of inhalation products that do not consider patient needs will fail.
  • Inhalation devices must be developed directly with the patients from early stage to commercialization, including feedback post market launch.
  • Patient centric drug product design together with digital technology will have a key role promoting successful inhalation therapy.

Nélio Drumond, Associate Director, Lead Process Scientist, Global Manufacturing Sciences, Drug Product, Takeda